Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Subjects: Drug Costs* ; Organizations, Nonprofit* ; Private Sector*
-
Source:
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics [J Law Med Ethics] 2021; Vol. 49 (1), pp. 6-9.Publisher: Cambridge University Press Country of Publication: England NLM ID: 9315583 Publication Model: Print Cited Medium:
Record details
-
Authors :
Pereira VS; 1Translational Neuropsychiatry Unit,Department of Clinical Medicine,Aarhus University,Risskov,Denmark.; Hiroaki-Sato VA
Subjects: Antidepressive Agents, Tricyclic/Antidepressive Agents, Tricyclic/Antidepressive Agents, Tricyclic/*pharmacology ; Antidepressive Agents, Tricyclic/Antidepressive Agents, Tricyclic/Antidepressive Agents, Tricyclic/*therapeutic use ; Drug Development/Drug Development/Drug Development/*history
-
Source:
Acta neuropsychiatrica [Acta Neuropsychiatr] 2018 Dec; Vol. 30 (6), pp. 307-322. Date of Electronic Publication: 2018 Feb 01.Publisher: Cambridge University Press Country of Publication: England NLM ID: 9612501 Publication Model: Print-Electronic
Record details
-
Authors :
Baraldi E; Enrico Baraldi, Ph.D., is Professor of Industrial Engineering and Management at Uppsala University. His research focuses on innovation studies, business strategy, industrial marketing and purchasing, and commercialization of science. Olof Lindahl, Ph.D., is an Assistant Professor of International Business at Uppsala University. His research focuses on multinational corporations, managing innovation, and strategy. Miloje Savic, Ph.D., is a senior adviser on public health and antimicrobial resistance at the Norwegian Institute of Public Health. David Findlay, M.B.A., was a Global Commercial Director for anti-infectives at GSK and has a B.Sc. in Experimental Psychology from Reading University and an M.B.A. specializing in international business strategy from the University of Bradford's Management Centre. Christine Årdal, Ph.D., is a Senior Advisor at the Norwegian Institute of Public Health, co-lead for the DRIVE-AB research project, and co-lead on the European Union's Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections. Her research focuses are within antibiotic and neglected disease policy, particularly in regards to innovation and access.; Lindahl O
Subjects: Anti-Bacterial Agents* ; Drug Discovery*; Drug Development/Drug Development/Drug Development/*organization & administration
-
Source:
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics [J Law Med Ethics] 2018 Jun; Vol. 46 (1_suppl), pp. 25-31.Publisher: Cambridge University Press Country of Publication: England NLM ID: 9315583 Publication Model: Print Cited Medium:
Record details